Acamprosate Completed Phase 3 Trials for Schizophrenic Disorders / Alcohol Dependence Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00006206COMBINE (Acamprosate/Naltrexone)
NCT00463346Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism